L-ascorbic acid exerts anti-microbial and anti-virulence effects against multi-drug resistant Burkholderia cepacia complex
Microbial Pathogenesis · 2026
DOI: 10.1016/j.micpath.2026.108409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Sourabh Rajendra Bhujbal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infection and Inflammation, Department of Biotechnology, School of Integrative Biology, Central University of Tamil Nadu, Thiruvarur, Tamil Nadu, 610…. Hauptthemen laut MEDLINE: Ascorbic Acid, Burkholderia cepacia complex, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Burkholderia cepacia complex (Bcc) encompasses a group of multi-drug resistant, Gram-negative bacilli that poses a significant threat to individuals with cystic fibrosis, and the immunocompromised population. Due to limitations with available anti-microbial therapeutics, alternative strategies using synthetic chemical compounds are widely being explored. Here, we evaluated the anti-microbial, anti-biofilm and anti-virulence effects of L-ascorbic acid against a clinical isolate of the B. cepacia complex (henceforth designated as B. cepacia for the sake of simplicity). Antibiotic susceptibility was assessed by the Kirby-Bauer's disk diffusion method, and β-lactamase production was confirmed by the iodometric assay. Broth microdilution revealed a minimum inhibitory concentration (MIC) of 5 mg/mL for L-ascorbic acid against B. cepacia. At sub-MIC levels, L-ascorbic acid delayed bacterial growth and prolonged the lag phase. Furthermore, when combined with a sub-inhibitory concentration of penicillin, L-ascorbic acid exhibited significant growth inhibition, indicating a strong additive effect. At a concentration of 1.25 mg/mL, L-ascorbic acid significantly reduced biofilm (51.30%) and exopolysaccharide production (57.83%). It also impaired bacterial swarming besides suppressing the hemolytic and urease functions of B. cepacia. Silver staining of protein electrophoresis by SDS-PAGE revealed a pronounced reduction in protein band intensity in the isolate treated with L-ascorbic acid (1.25 mg/mL). Docking studies suggest that L-ascorbic acid may interact with biofilm-associated proteins in B. cepacia by binding to key regulatory proteins, including the acyl-homoserine lactone synthase (CepI), the CepR receptor, the BceF tyrosine kinase domain, and PhzA/B. Altogether, L-ascorbic acid demonstrated anti-microbial and anti-biofilm effects, complemented by in silico evidence suggesting possible interactions with quorum sensing-associated proteins, supporting its likely role as an adjunct anti-infective under in vitro conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infection and Inflammation, Department of Biotechnology, School of Integrative Biology, Central University of Tamil Nadu, Thiruvarur, Tamil Nadu, 610 005, India.
- Quorum Sensing and Biofilm Research Laboratory, Centre for Infectious Diseases, Department of Microbiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha…
- Department of Medical Microbiology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
- Division of Microbiology, Department of Clinical Laboratory Services and Translational Research, Malabar Cancer Centre (Post Graduate Institute of Oncology Sciences and Research), Thalassery, Kerala, 670 103, India.
- Molecular Pharmacology and Toxicology, Department of Biotechnology, School of Integrative Biology, Central University of Tamil Nadu, Thiruvarur, Tamil Nadu, 610 005, India. Electronic address: latchoumycandane@cutn.ac.i…
- Infection and Inflammation, Department of Biotechnology, School of Integrative Biology, Central University of Tamil Nadu, Thiruvarur, Tamil Nadu, 610 005, India. Electronic address: shankarem@cutn.ac.in.
Zitieren
APA
Bhujbal, S. R., Balasanker, P., Pathoor, N. N., Anshad, A. R., Atchaya, M., Naik, J. S., Ganesh, P. S., Gautam, V., Rudrapathy, P., Calivarathan, L., & Shankar, E. M. (2026). L-ascorbic acid exerts anti-microbial and anti-virulence effects against multi-drug resistant Burkholderia cepacia complex. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108409
Vancouver
Bhujbal SR, Balasanker P, Pathoor NN, Anshad AR, Atchaya M, Naik JS, et al. L-ascorbic acid exerts anti-microbial and anti-virulence effects against multi-drug resistant Burkholderia cepacia complex. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108409
BibTeX
@article{Bhujbal2026,
author = {Bhujbal, Sourabh Rajendra and Balasanker, Panayanthatta and Pathoor, Naji Naseef and Anshad, Abdul R and Atchaya, Muthuvel and Naik, Janavath S and Ganesh, Pitchaipillai Sankar and Gautam, Vikas and Rudrapathy, Parthiban and Calivarathan, Latchoumycandane and Shankar, Esaki M},
title = {L-ascorbic acid exerts anti-microbial and anti-virulence effects against multi-drug resistant Burkholderia cepacia complex},
journal = {Microbial Pathogenesis},
year = {2026},
doi = {10.1016/j.micpath.2026.108409}
}
EUVIMED